MEDlight N-LINEpro - Page 23

USER MANUAL & TECHNICAL DESCRIPTION
N-LINEpro_User Manual_2018-09-20.doc
MEDlight GmbH
Werrestr. 94
32049 Herford
Germany
Phone: +49 5221 99429-0
Fax: +49 5221 99429-40
e-mail: info@medlight.eu
www.medlight.eu
Page 23 of 30
There is no treatment scheme uniformly applicable to all patients. Phototherapy should always be
adapted to the individual needs of a patient. All dosage indications are mean values which may vary
according to skin condition and sensitivity.
UVB – Initial Doses
Skin Type
UVB 311 nm (J/cm²)
I
0.20
II
0.30
III
0.50
IV
0.60
Source: Prof. Dr. E. Hölze, et Al. ‚Empfehlungen zur Phototherapie und Photochemotherapie‘ DDG Berlin 2009
Depending on the photosensitivity of the patient and the clinical picture, the treatment dose can be
individually further increased accordingly.
Due to individual skin sensitivity, itching / skin irritation may occur following initial treatment. Patients
should be informed of this prior to the commencement of therapy. Should itching / irritation occur,
doses should not be increased for several days until these complaints have subsided.
Emollient treatment of the skin is recommended after every phototherapy treatment.
UVB 311 nm - Dose Examples
Treatment scheme:
Example for skin type II
Day 1
0.30 J/cm²
Day 6
0.60 J/cm²
Day 2
0.35 J/cm²
Day 7
0.60 J/cm²
Day 3
0.40 J/cm²
Day 8
0.70 J/cm²
Day 4
0.45 J/cm²
Day 9
0.70 J/cm²
Day 5
0.50 J/cm²
Day 10
0.80 J/cm²
Depending on the individual response of the patient the dose can be accordingly increased in smaller or
bigger steps. An increase of more than 0.2 J/cm² should never be exceeded.
UVB - Follow-Up Treatment
After the treated lesions have healed, treatment should be phased out using the protocol set out below.
This gradual withdrawal is needed to achieve a prolonged recurrence-free period.
1st follow-up week:
3 x the last selected dose of the therapy
2nd follow-up week:
2 x the last selected dose of the therapy
3rd follow-up week:
1 x the last selected dose of the therapy
4th follow-up week:
1 x the last selected dose of the therapy